five

Available IPD datapackage for study 'A Randomized, Double-Blind, Placebo Controlled Trial Evaluating the Safety and Efficacy of Etanercept 50 mg Once Weekly Compared With 25 mg Twice Weekly in Subjects With Ankylosing Spondylitis'

收藏
DataCite Commons2025-07-07 更新2026-05-07 收录
下载链接:
https://search.vivli.org/doiLanding/dataPackages/PR00006770.0
下载链接
链接失效反馈
官方服务:
资源简介:
The purpose of this study is to compare efficacy, pharmacokinetics, and safety of investigational formulations of etanercept administered as 50 mg once weekly with 25 mg twice weekly and placebo in patients with ankylosing spondylitis (AS).
提供机构:
Vivli
创建时间:
2025-07-07
二维码
社区交流群
二维码
科研交流群
商业服务